Back to Journals » Clinical and Experimental Gastroenterology » Volume 11

Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin

Total article views   Abstract views HTML views PDF downloads Totals
4,234 Dovepress* 3,240 564+ 365 3,804
PubMed Central* 0 430 189 430
Totals 3,240 994 554 4,234
*Since 24 September 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
14 0 0 0 6 8

View citations on PubMed Central and Google Scholar